ATEC
Price
$15.90
Change
+$0.22 (+1.40%)
Updated
Sep 3 closing price
Capitalization
2.35B
56 days until earnings call
JNDOF
Price
$22.75
Change
-$3.25 (-12.50%)
Updated
Oct 13 closing price
Capitalization
1.28B
Interact to see
Advertisement

ATEC vs JNDOF

Header iconATEC vs JNDOF Comparison
Open Charts ATEC vs JNDOFBanner chart's image
Alphatec Holdings
Price$15.90
Change+$0.22 (+1.40%)
Volume$2.08M
Capitalization2.35B
Jins
Price$22.75
Change-$3.25 (-12.50%)
Volume$300
Capitalization1.28B
ATEC vs JNDOF Comparison Chart in %
Loading...
ATEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATEC vs. JNDOF commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEC is a Buy and JNDOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ATEC: $15.90 vs. JNDOF: $22.75)
Brand notoriety: ATEC and JNDOF are both not notable
ATEC represents the Medical/Nursing Services, while JNDOF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ATEC: 90% vs. JNDOF: 100%
Market capitalization -- ATEC: $2.35B vs. JNDOF: $1.28B
ATEC [@Medical/Nursing Services] is valued at $2.35B. JNDOF’s [@Pharmaceuticals: Other] market capitalization is $1.28B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.05B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.15B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.6B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATEC’s FA Score shows that 0 FA rating(s) are green whileJNDOF’s FA Score has 1 green FA rating(s).

  • ATEC’s FA Score: 0 green, 5 red.
  • JNDOF’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATEC and JNDOF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATEC’s TA Score shows that 5 TA indicator(s) are bullish.

  • ATEC’s TA Score: 5 bullish, 5 bearish.

Price Growth

ATEC (@Medical/Nursing Services) experienced а -1.73% price change this week, while JNDOF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.08%. For the same industry, the average monthly price growth was +1.73%, and the average quarterly price growth was +23.90%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.09%. For the same industry, the average monthly price growth was +6.96%, and the average quarterly price growth was +33.57%.

Reported Earning Dates

ATEC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.08% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-2.09% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATEC($2.35B) has a higher market cap than JNDOF($1.28B). ATEC YTD gains are higher at: 73.203 vs. JNDOF (0.000). JNDOF has higher annual earnings (EBITDA): 13.3B vs. ATEC (-46.79M). JNDOF has more cash in the bank: 11.4B vs. ATEC (157M). ATEC has less debt than JNDOF: ATEC (587M) vs JNDOF (5.61B). JNDOF has higher revenues than ATEC: JNDOF (89.8B) vs ATEC (682M).
ATECJNDOFATEC / JNDOF
Capitalization2.35B1.28B184%
EBITDA-46.79M13.3B-0%
Gain YTD73.2030.000-
P/E RatioN/A47.34-
Revenue682M89.8B1%
Total Cash157M11.4B1%
Total Debt587M5.61B10%
FUNDAMENTALS RATINGS
ATEC vs JNDOF: Fundamental Ratings
ATEC
JNDOF
OUTLOOK RATING
1..100
1741
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
54100
SMR RATING
1..100
10062
PRICE GROWTH RATING
1..100
3870
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/a45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNDOF's Valuation (29) in the null industry is significantly better than the same rating for ATEC (99) in the Medical Specialties industry. This means that JNDOF’s stock grew significantly faster than ATEC’s over the last 12 months.

ATEC's Profit vs Risk Rating (54) in the Medical Specialties industry is somewhat better than the same rating for JNDOF (100) in the null industry. This means that ATEC’s stock grew somewhat faster than JNDOF’s over the last 12 months.

JNDOF's SMR Rating (62) in the null industry is somewhat better than the same rating for ATEC (100) in the Medical Specialties industry. This means that JNDOF’s stock grew somewhat faster than ATEC’s over the last 12 months.

ATEC's Price Growth Rating (38) in the Medical Specialties industry is in the same range as JNDOF (70) in the null industry. This means that ATEC’s stock grew similarly to JNDOF’s over the last 12 months.

JNDOF's P/E Growth Rating (98) in the null industry is in the same range as ATEC (100) in the Medical Specialties industry. This means that JNDOF’s stock grew similarly to ATEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATECJNDOF
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
72%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
70%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
5%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
3%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ATEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMWX18.870.15
+0.80%
Templeton World A
WCMRX25.730.10
+0.39%
WCM Focused International Growth Inv
BRSBX14.510.04
+0.28%
MFS Blended Research Small Cap Eq B
GLNAX24.380.03
+0.12%
MFS Global New Discovery A
JUSQX18.55-0.02
-0.11%
JPMorgan US Small Company R4

ATEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATEC has been loosely correlated with LAB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATEC jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATEC
1D Price
Change %
ATEC100%
+1.40%
LAB - ATEC
44%
Loosely correlated
+4.03%
XRAY - ATEC
39%
Loosely correlated
+0.72%
TFX - ATEC
37%
Loosely correlated
-0.78%
SIBN - ATEC
34%
Loosely correlated
-1.40%
DXCM - ATEC
34%
Loosely correlated
+6.22%
More

JNDOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNDOF has been closely correlated with SGHT. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if JNDOF jumps, then SGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNDOF
1D Price
Change %
JNDOF100%
N/A
SGHT - JNDOF
75%
Closely correlated
-1.81%
ALGN - JNDOF
60%
Loosely correlated
-3.50%
HYPR - JNDOF
43%
Loosely correlated
-7.44%
ATEC - JNDOF
33%
Poorly correlated
+1.40%
SDMHF - JNDOF
29%
Poorly correlated
+2.51%
More